5 of Last Week's Biggest Winners

What's better than momentum? Mo' momentum. Let's take a closer look at five of this past week's biggest scorchers.

Company

Oct. 18

Weekly Gain

Geron (NASDAQ: GERN  )

$4.28

39%

SolarCity  (NASDAQ: SCTY  )

$59.46

26%

NQ Mobile  (NYSE: NQ  )

$24.92

24%

Chipotle Mexican Grill  (NYSE: CMG  )

$509.74

15%

Glu Mobile  (NASDAQ: GLUU  )

$3.30

10%

Source: Barron's.

Let's start with Geron. The low-priced biotech soared after MLV & Co. initiated coverage with a bullish $6.50 price target. It's been a great run for Geron in recent weeks. The stock has nearly tripled since the beginning of September. Last week's analyst upgrade validates the gains.

SolarCity continued its massive run as the Elon Musk-backed installer of solar energy products succeeds in getting the market to buy into its model of installment payment-based installations that match the savings over traditional electric energy. SolarCity's rally continued despite the dilutive nature of a secondary stock and convertible debt offering.

NQ Mobile, a global provider of Internet services, moved higher after setting up a media event on Tuesday to introduce what it's calling "an exciting new product." The company will share the spotlight with Apple, which will be showing off its new iPads later in the day, but NQ Mobile is still turning heads by building up the hype.

Chipotle Mexican Grill once again proved why it's the class act of burrito rollers. The fast-casual poster child served up tasty quarterly results, fueled by a 6.2% spike in comps. Chipotle expects to open as many as 195 more locations next year. 

Finally, Glu Mobile moved higher after B. Riley upgraded shares of the mobile-app publisher. B. Riley pushed its price target from $2.75 to $3.75 in upgrading its outlook from "neutral" to "buy."

Glu Mobile and other casual-gaming specialists have been out of favor, but that's starting to change now that Candy Crush Saga creator King is generating buzz for its upcoming IPO.

Keep the good vibes coming
The best way to play the biotech space is to find companies that shun the status quo and instead discover revolutionary, groundbreaking technologies. In The Motley Fool's brand-new free report "2 Game-Changing Biotechs Revolutionizing the Way We Treat Cancer," find out about a new technology that Big Pharma is endorsing through partnerships, and the two companies that are set to profit from this emerging drug class. Click here to get your copy today.


Read/Post Comments (0) | Recommend This Article (2)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2690781, ~/Articles/ArticleHandler.aspx, 8/30/2014 10:40:47 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement